IDEXX Laboratories, Inc.
IDXX
$430.12
$1.090.25%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 954.29M | 975.54M | 1.00B | 964.10M | 901.60M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 954.29M | 975.54M | 1.00B | 964.10M | 901.60M |
| Cost of Revenue | 383.63M | 379.51M | 384.42M | 371.03M | 375.43M |
| Gross Profit | 570.66M | 596.04M | 619.16M | 593.07M | 526.17M |
| SG&A Expenses | 251.25M | 176.67M | 238.41M | 241.48M | 229.05M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 692.60M | 610.15M | 678.28M | 665.14M | 656.30M |
| Operating Income | 261.69M | 365.39M | 325.30M | 298.96M | 245.30M |
| Income Before Tax | 256.39M | 298.91M | 259.06M | 295.48M | 239.67M |
| Income Tax Expenses | 40.24M | 66.07M | 55.76M | 59.90M | 45.15M |
| Earnings from Continuing Operations | 216.15M | 232.84M | 203.30M | 235.58M | 194.52M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 216.15M | 232.84M | 203.30M | 235.58M | 194.52M |
| EBIT | 261.69M | 365.39M | 325.30M | 298.96M | 245.30M |
| EBITDA | 295.39M | 399.53M | 357.49M | 328.86M | 275.04M |
| EPS Basic | 2.64 | 2.83 | 2.46 | 2.84 | 2.34 |
| Normalized Basic EPS | 1.96 | 2.74 | 2.42 | 2.22 | 1.80 |
| EPS Diluted | 2.62 | 2.80 | 2.44 | 2.81 | 2.31 |
| Normalized Diluted EPS | 1.94 | 2.71 | 2.40 | 2.20 | 1.78 |
| Average Basic Shares Outstanding | 81.85M | 82.30M | 82.63M | 83.10M | 83.09M |
| Average Diluted Shares Outstanding | 82.54M | 83.06M | 83.39M | 83.96M | 83.93M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
